These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16780801)

  • 1. A biophysical approach to the optimisation of dendritic-tumour cell electrofusion.
    Sukhorukov VL; Reuss R; Endter JM; Fehrmann S; Katsen-Globa A; Gessner P; Steinbach A; Müller KJ; Karpas A; Zimmermann U; Zimmermann H
    Biochem Biophys Res Commun; 2006 Aug; 346(3):829-39. PubMed ID: 16780801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrofusion generates diverse DC-tumour cell hybrids for cancer immunotherapy.
    Weise JB; Hilpert F; Heiser A; Görögh T; Meyer JE; Weimer J; Krüger C; Rosenau A; Wieckhorst W; Arnold N; Pfisterer J; Kabelitz D; Maune S
    Anticancer Res; 2004; 24(2B):929-34. PubMed ID: 15161046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cell hybrids via a fusogenic cell line.
    Cheong SC; Blangenois I; Franssen JD; Servais C; Phan V; Trakatelli M; Bruyns C; Vile R; Velu T; Brandenburger A
    J Gene Med; 2006 Jul; 8(7):919-28. PubMed ID: 16602137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of hybrid cells obtained by dendritic cell/tumour cell fusion in a T-47D breast cancer cell line model indicate their potential as anti-tumour vaccines.
    Serhal K; Baillou C; Ghinea N; Fontanges P; Dupuy FP; Lemoine FM; Lacave R
    Int J Oncol; 2007 Dec; 31(6):1357-65. PubMed ID: 17982663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell hybridization by electrofusion on filters.
    Ramos C; Bonenfant D; Teissie J
    Anal Biochem; 2002 Mar; 302(2):213-9. PubMed ID: 11878799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma cells deteriorate the biophysical properties of dendritic cells.
    Zeng Z; Yao W; Xu X; Xu G; Long J; Wang X; Wen Z; Chien S
    Cell Biochem Biophys; 2009; 55(1):33-43. PubMed ID: 19582594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of anti-tumour effector T cells from naïve T cells by stimulation with dendritic/tumour fusion cells.
    Ishida A; Tanaka H; Hiura T; Miura S; Watanabe S; Matsuyama K; Kuriyama H; Tanaka J; Kagamu H; Gejyo F; Yoshizawa H
    Scand J Immunol; 2007 Nov; 66(5):546-54. PubMed ID: 17953530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
    Deng YJ; Xia JC; Zhou J; Wang QJ; Zhang PY; Zhang LJ; Rong TH
    Ai Zheng; 2007 Feb; 26(2):137-41. PubMed ID: 17298741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of cell electrofusion in vitro and in vivo is cell line dependent.
    Salomskaite-Davalgiene S; Cepurniene K; Satkauskas S; Venslauskas MS; Mir LM
    Anticancer Res; 2009 Aug; 29(8):3125-30. PubMed ID: 19661325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma.
    Draube A; Beyer M; Schumer S; Thomas RK; von Tresckow B; Koslowsky TC; Krieglstein CF; Schultze JL; Wolf J
    J Immunother; 2007; 30(4):359-69. PubMed ID: 17457211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formation.
    Li LH; Hensen ML; Zhao YL; Hui SW
    Biophys J; 1996 Jul; 71(1):479-86. PubMed ID: 8804630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma cells.
    Trontelj K; Rebersek M; Kanduser M; Serbec VC; Sprohar M; Miklavcic D
    Bioelectrochemistry; 2008 Nov; 74(1):124-9. PubMed ID: 18667367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.
    Zhang Y; Ma B; Zhou Y; Zhang M; Qiu X; Sui Y; Zhang X; Ma B; Fan Q
    Breast Cancer Res Treat; 2007 Nov; 105(3):277-86. PubMed ID: 17187233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutions.
    Schmitt JJ; Zimmermann U
    Biochim Biophys Acta; 1989 Jul; 983(1):42-50. PubMed ID: 2758049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma.
    Papewalis C; Fassnacht M; Willenberg HS; Domberg J; Fenk R; Rohr UP; Schinner S; Bornstein SR; Scherbaum WA; Schott M
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):215-22. PubMed ID: 16886963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton.
    Zeng Z; Xu X; Zhang Y; Xing J; Long J; Gu L; Wang X; Sun D; Ka W; Yao W; Wen Z; Chien S
    Cell Motil Cytoskeleton; 2007 Mar; 64(3):186-98. PubMed ID: 17183544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines.
    Scott-Taylor TH; Pettengell R; Clarke I; Stuhler G; La Barthe MC; Walden P; Dalgleish AG
    Biochim Biophys Acta; 2000 Mar; 1500(3):265-79. PubMed ID: 10699368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
    Acharya AP; Clare-Salzler MJ; Keselowsky BG
    Biomaterials; 2009 Sep; 30(25):4168-77. PubMed ID: 19477505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.